New York-based investment firm Deerfield Management is leading a $40 million Series A funding round for Baltimore’s Dracen Pharmaceuticals Inc. Dracen, a year-old biotechnology company, is developing pharmaceutical technology born out of Johns Hopkins University. The company disclosed its latest equity financing round in a filing with the U.S. Securities and Exchange Commission earlier this year, but CEO Tom Estok had declined to disclose investors. The SEC filing noted at least nine investors…
from https://www.bizjournals.com/baltimore/news/2018/03/22/health-care-focused-deerfield-management-leads.html?ana=RSS&s=article_search
via http://baltimorecheckbook.tumblr.com/post/172142244732
No comments:
Post a Comment